Drug Profile
AL 003
Alternative Names: AL-003Latest Information Update: 21 Oct 2022
Price :
$50
*
At a glance
- Originator AbbVie; Alector
- Class Antidementias; Monoclonal antibodies
- Mechanism of Action CD33 antigen inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Alzheimer's disease